Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Sep 14, 2015 |
signed chap.238 delivered to governor |
Jun 18, 2015 |
returned to senate passed assembly ordered to third reading rules cal.535 substituted for a5805a |
Jun 18, 2015 |
substituted by s4857a |
Jun 17, 2015 |
ordered to third reading rules cal.535 rules report cal.535 reported |
Jun 16, 2015 |
reported referred to rules |
Jun 12, 2015 |
print number 5805a |
Jun 12, 2015 |
amend (t) and recommit to higher education |
Mar 05, 2015 |
referred to higher education |
Assembly Bill A5805A
Signed By Governor2015-2016 Legislative Session
Sponsored By
MCDONALD
Archive: Last Bill Status Via S4857 - Signed by Governor
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
Alec Brook-Krasny
Albert A. Stirpe
Phil Steck
David Weprin
multi-Sponsors
Vivian Cook
David DiPietro
Michael J. Fitzpatrick
Sandy Galef
2015-A5805 - Details
2015-A5805 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5805 2015-2016 Regular Sessions I N A S S E M B L Y March 5, 2015 ___________ Introduced by M. of A. McDONALD -- read once and referred to the Commit- tee on Higher Education AN ACT to amend the education law, in relation to authorizing pharma- cists to perform collaborative drug therapy management, and to amend chapter 21 of the laws of 2011 amending the education law relating to authorizing pharmacists to perform collaborative drug therapy manage- ment with physicians in certain settings, in relation to making such provisions permanent THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 6801-a of the education law, as added by chapter 21 of the laws of 2011, is amended to read as follows: S 6801-a. Collaborative drug therapy management [demonstration program]. 1. As used in this section, the following terms shall have the following meanings: a. "CLINICAL SERVICES" SHALL MEAN THE COLLECTION AND INTERPRETATION OF PATIENT DATA FOR THE PURPOSE OF INITIATING, MODIFYING AND MONITORING DRUG THERAPY WITH ASSOCIATED ACCOUNTABILITY AND RESPONSIBILITY FOR OUTCOMES IN A DIRECT PATIENT CARE SETTING. B. "Collaborative drug therapy management" shall mean the performance of CLINICAL services by [a pharmacist] PHARMACISTS relating to the review, evaluation and management of drug therapy to a patient, who is being treated by a physician, PHYSICIAN ASSISTANT OR NURSE PRACTITIONER for a specific disease or disease [state] STATES, in accordance with a written agreement or protocol with a voluntarily participating physician, PHYSICIAN ASSISTANT OR NURSE PRACTITIONER and in accordance with the policies, procedures, and protocols of [the] A facility OR MEDICAL PRACTICE. Such agreement or protocol as entered into by the physician, PHYSICIAN ASSISTANT OR NURSE PRACTITIONER and [a pharmacist] PHARMACISTS, may include[, and shall be limited to]: EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD06620-05-5
co-Sponsors
Albert A. Stirpe
Phil Steck
David Weprin
Barbara Lifton
multi-Sponsors
Vivian Cook
David DiPietro
Michael J. Fitzpatrick
Sandy Galef
2015-A5805A (ACTIVE) - Details
2015-A5805A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5805--A 2015-2016 Regular Sessions I N A S S E M B L Y March 5, 2015 ___________ Introduced by M. of A. McDONALD, BROOK-KRASNY, STIRPE, STECK, WEPRIN, LIFTON, ORTIZ, CLARK, FAHY, LUPINACCI, WALTER, BRINDISI, KEARNS, OTIS, DUPREY, GOTTFRIED, LAVINE, SIMANOWITZ, LUPARDO, BUTLER, GARBARINO, PEOPLES-STOKES -- Multi-Sponsored by -- M. of A. COOK, DiPIETRO, FITZPATRICK, GALEF, HAWLEY, HOOPER, McLAUGHLIN, SCHIMMINGER, THIELE, TITONE -- read once and referred to the Committee on Higher Education -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the education law, in relation to authorizing pharma- cists to perform collaborative drug therapy management, and to amend chapter 21 of the laws of 2011 amending the education law relating to authorizing pharmacists to perform collaborative drug therapy manage- ment with physicians in certain settings, in relation to extending such provisions THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 6801-a of the education law, as added by chapter 21 of the laws of 2011, is amended to read as follows: S 6801-a. Collaborative drug therapy management demonstration program. 1. As used in this section, the following terms shall have the following meanings: a. "BOARD" SHALL MEAN THE STATE BOARD OF PHARMACY AS ESTABLISHED BY SECTION SIXTY-EIGHT HUNDRED FOUR OF THIS ARTICLE. B. "CLINICAL SERVICES" SHALL MEAN THE COLLECTION AND INTERPRETATION OF PATIENT DATA FOR THE PURPOSE OF INITIATING, MODIFYING AND MONITORING DRUG THERAPY WITH ASSOCIATED ACCOUNTABILITY AND RESPONSIBILITY FOR OUTCOMES IN A DIRECT PATIENT CARE SETTING. C. "Collaborative drug therapy management" shall mean the performance of CLINICAL services by a pharmacist relating to the review, evaluation and management of drug therapy to a patient, who is being treated by a physician for a specific disease or ASSOCIATED disease [state] STATES, in accordance with a written agreement or protocol with a voluntarily participating physician and in accordance with the policies, procedures, and protocols of the facility. Such agreement or protocol as entered
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.